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The detection of so-called lineage-specific antigens has become a
standard tool of pathologists for the identification of metastasis of
cancers with unknown primary site or of disseminated cancer cells
in haemopoietic compartments such as bone marrow or in lymph
nodes (Pantel et al, 1994). Marker proteins used for the identifica-
tion of epithelial cells are the cytokeratins and the mucins
(Dearnaley et al, 1983). Whilst the cytokeratins have been well
described as part of the cytoskeleton of epithelial cells the function
of the mucins remains less clear. The mucins are a class of highly
glycosylated proteins. The main interest in mucin-research was
focused on their expression on epithelial cancer cells and their
possible usefulness as tumour markers and targets for antineo-
plastic immunotherapy so far (Gendler and Spicer, 1995; Patton et
al, 1995). The expression of the muc1 protein by haemopoietic
cells has recently been described by two groups. Brugger et al
have investigated its expression by FACS-analysis and Dent et al
demonstrated muc1 transcription in blood cells by molecular
methods (Brugger et al, 1999; Dent et al, 1999).
The luminal membrane of human breast epithelial cells contains
a variety of mucin-like proteins, some of these named human milk
fat globule proteins. These HMFG-proteins have been discussed
as surface differentiation markers as well as proteins with anti-
infectious function on milk vesicles. Two of these proteins have
been characterized and cloned by Larocca et al. One protein has a
molecular weight of 46 kD (BA46), the other is approximately 70
kD sized (BA70). Homologies with other mucin genes are neither
described for the BA46 nor for the BA70 gene. Both proteins have
been discussed as targets for immunotherapy and radioimaging of
breast cancer (Larocca et al, 1990; 1991). The BA46 antigen has
recently been renamed lactadherin. For lactadherin an anti-infec-
tious effect protecting against rota-virus infections has been shown
(Newburg, 1999). A weak transcription of both sequences has
been detected in Raji cells, however, their expression neither in
other haemopoietic cell lines nor in haemopoietic specimens from
healthy female and male subjects has been considered so far.
Here we investigate the transcription and expression of BA46
and BA70 in haemopoietic cells by molecular and immunological
approaches.
MATERIAL AND METHODS
Cell lines and clinical specimens
Breast cancer cell lines MCF-7, MDA-MB453, and haemopoietic
lines ST486, HL60, K562, Raji, and Namalwa were purchased
from the ATCC. Rat fibroblast line Rat-2 was used as negative
control in immunocytochemistry. Cell lines were maintained in
RPMI-1640 or MEM, supplemented with fetal calf sera and 1%
L-glutamine at 37°C and 5% CO2 according to the manufacturer’s
instructions following standard methods. Patients specimens
consisting of bone marrow (n = 11), G-CSF mobilized blood stem
cell collections (n = 3), and one pericardial effusion were obtained
from healthy volunteers and from cancer patients after informed
consent. All cell lines and clinical specimens investigated are
listed in Table 1. Clinical samples were subjected to mononucle-
ated cell separation by ficoll-centrifugation prior to analysis.
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RNA was extracted with guanidinium thiocyanate according the
method from Sacchi and Chomczinsky. 15 mg of RNA were sepa-
rated by electrophoresis at 50 V through 0.8% agarose gels.
Nucleic acid fragments were stained with ethidium bromide for
documentation. Capillary blot onto positively charged nylon
membranes (Zeta-probe, BioRad, Munich, Germany) was
performed under alkaline conditions. Hybridization assay was
carried out with g-32P-labelled oligonucleotides complementary to
the mRNA-sequence of the 46 kD and 70 kD milk fat globule
proteins. Hybridization with an oligonucleotide complementary to
the human b-actin mRNA served as positive and with an oligo-
nucleotide identical (sense) to the BA46- and BA70-sequence as
negative control (Kruger and Pulz, 1991; Duggan et al, 1997). The
sequence as oligonucleotides for hybridization and PCR-amplifi-
cation is shown in Table 2.
Reverse transcriptase polymerase chain reaction and
sequence analysis
One microgram of mRNA was subjected to reverse transcription
with primers shown in Table 2. In general, reverse transcriptase
polymerase chain reaction was performed as previously described.
The house-keeping gene b-actin was amplified as positive control,
H2O was used as negative control. Sequence analysis of amplified
fragments was performed in an automated sequencer (Applied
Biosystems). PCR-products were sequenced directly by the
dideoxynucleotide chain termination method using fluorescent
labels with dye terminator kits directly. Comparison of sequences
obtained with the BA46 and BA70 mRNA was made with a soft-
ware using a Needleman & Wunsch algorithm at the EMBO,
Heidelberg, Germany (Kruger et al, 1996).
To ensure the specific amplification of mRNA-derived cDNA in
PCR-experiments, cellular DNA extracted from cell lines MCF7
and Raji was subjected to amplification with milkfat-globuline-
specific primers. The amplicons produced by this approach were
significantly larger than those obtained from rtPCR with cDNA
indicating the presence of introns in cellular DNA derived PCR-
products.
Antibodies
Two polyclonal antibodies against epitopes of the 46 kD and
70 kD milk fat globulin proteins were raised in rabbits grown
under pathogen-free conditions. Peptides 717 (DFIHD-
VNKKHKEFV, BA46) and 718 (RSKWSERTRKPLEALY,
BA70) were synthesized according to the corresponding mRNA
sequences of BA46 and BA70. Peptides were linked to keyhole
limpet haemocyanin and two rabbits were immunized on days 0,
14, 28 and 56, each with a different peptide. Animals were bled
and the specific reactivity of the sera was determined by enzyme-
linked immunosorbent assay. Subsequently, polyclonal antibodies
P717 and P718 were purified by immunoaffinity using peptides
717 and 718 as specific matrix components. Enriched polyclonal
antibodies were used in Western-blot analysis and for immunocy-
tochemistry.
Immunocytochemistry
Cells subjected to immunocytochemistry were mobilized from
culture flasks with cell scrapers to avoid trypsinization.
Immunocytochemistry was carried out following standard proto-
cols. After incubation with polyclonal antibodies P717 and P718,
antibody-labelled cells were detected by a sheep-anti-rabbit
HMF G-expression 875
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Table 1 Cell lines and clinical samples
Cell line/sample Description Diagnosis Gender
MCF-7 Cell line Breast cancer
MDA-MB453 Cell line Breast cancer
K-562 Cell line CML
HL-60 Cell line AML
Raji Cell line NHL
Namalwa Cell line NHL
ST-486 Cell line NHL
1B M B C F
2B M V D M
3B M V D M
4 BM VD Not known
5L P V D M
6L P B C F
7B M V D F
8B M V D M
9B M V D M
10 PE LC M
11 BM CC M
12 BM VD M
13 LP VD M
14 BM VD F
15 BM VD M
16 BM VD F
17 BM VD M
Abbreviations: BM, bone marrow; LP, leukapheresis; CML, chronic myeloid
leukaemia; AML, acute myeloid leukaemia; NHL, non-Hodgkin’s lymphoma;
BC, breast cancer; VD, healthy volunteer donor; LC, lung cancer; CC, colon
cancer; M, male; F, female
Table 2 Oligionucleotides for Northern hybridization and rtPCR
Oligonucleotide Sequence Localization
46H CACACATCACATTCCCATGGTGGCCTCAAG 1021–1050
70H CATCTGCCGGCACCTGCTGCCCCGGGTCCA 126–155
b-actin CGGTTCCGCTGCCCTGAGGCACTCTTGCAG 801–830
NC46 CTTGAGGCCACCATGGGAATGTGATGTGTG 1021–1050
NC70 GATCCTTCTCACCGTGCACAATCAAGGCGG 161–190
46PCRs TAAGCCCCGTCCCCTAAC 848–865
46PCRa GCTGGGCTTCAGGACAAG 1211–1194
Amplicon length 364Bp
70PCRs AGCCTCTAGAAGCCCTCTATGG 29–50
70PCRa AGGTTGTGTTTGCCTTCTGG 278–259
Amplicon length 250Bpalkaline phosphatase conjugate (P717, P718) followed by an
enzyme-mediated colour reaction. Primary antibodies were used
in dilutions between 1:2 up to 1:1000. Positive cells and non-
stained cells were counted and the percentage of stained cells was
calculated according to Pantel et al (1994). The percentages of
stained cells were compared by univariate analysis (least signifi-
cance difference) using the computer software WinSTAT (Kalmia
Co. Inc; Cambridge, USA).
Western blot analysis
Eighty micrograms of total cellular protein were separated by
SDS-polyacrylamide gel electrophoresis through 5%, 7.5%,
12.5% and 15% gels. This selection of acrylamide allowed separa-
tion of proteins between 10 and 200 kD molecular weight. All gels
were prepared in duplicate. One gel of each run was subjected to
silver stain, the other was blotted onto a nitrocellulose membrane.
Immunoblot analysis was performed following standard protocols
with antibodies P717 and P718 (Mohanam et al 1997).
RESULTS
Transcription of the BA46 and BA70 messenger-RNA could be
detected by specific oligonucleotide-hybridization in all cell lines
and clinical samples investigated. Co-hybridization with the
control oligonucleotide homologue to the sense-sequence of the
BA46 mRNA remained negative in all cases (Table 3) (Figure 1).
Reverse transcriptase polymerase chain reaction with primers
for the sequences of the BA46 and the BA70 proteins produced
nucleic acid fragments of 364 bp and 270 bp in all cases investi-
gated. Sequence analysis of PCR-products and comparison to the
BA46 and BA70 mRNA sequences using a Needleman and
Wunsch algorithm confirmed identity for all cell lines and for
eight clinical samples investigated (Table 3). The result of
sequence comparison for the BA70 sequence shows (Figure 2),
data for the BA46 sequence are not shown.
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Table 3 Results of Northern-blot, reverse transcriptase polymerase chain reaction, and sequence analysis
Specimen 46H 70H b-actin NC NC 46PCR 46seq 70PCR 70seq
46 70
MCF-7 + + + – – + + + +
MDA-MB453 + + + – – + + + +
K-562 + + + – – + + + +
HL-60 + + + – – + + + +
Raji + + + – – + + + +
Namalwa + + + – – + + + +
ST-486 + + + – – + + + +
1++ +
2+ +
3++ + + + ++
4++ +
5++ +
6+ +
7++ + + + ++
8+ +
9++ +
10 + +
11 + +
12 +++ +
13 +++ +
14 +++ +
15 ++
16 + + ++
17 + + ++
+, positive; –, negative; empty, not done
Figure 1 Northern blot hybridization with b-actin- (top), BA46- (middle), and
BA70- (bottom) oligonucleotides. Lanes: 1) MCF7, 2) K562, 3) H2O,
4) Patient #9, 5) Patient #3, 6) ST486, 7) HL60.HMF G-expression 877
British Journal of Cancer (2000) 83(7), 874–879 © 2000 Cancer Research Campaign
The results of immunological experiments with polyclonal anti-
bodies P717 and P718 were divergent for Western blot analysis
and for immunocytochemistry. Antibody P717 showed in Western
blots a strong reaction with a protein of approximately 30 kD
molecular weight. This protein was detected in breast cancer cells,
lymphatic and myeloid cells. The expression seems to be strongest
in cell lines MCF7, MDA-MB453, K562, and Raji. Furthermore,
an additional reaction was seen in the range of 80 kD
molecular mass. The intensity of reaction varied between the cells,
however, the reaction was strongest in breast cancer cell extracts
(Figure 3).
Using antibody P718, a strong reaction with a protein of 28 kD
molecular mass was detected in total protein extracted from breast
cancer cell line MCF7 and MDA-MB453. A second protein in the
range of 85 kD was detected in lysates from all cell lines indepen-
dent from their provenance (Figure 3).
Figure 2 Nucleic acid sequences of the BA70 mRNA compared with sequences of amplicons obtained by rtPCR with primer pairs 70PCRs/70PCRa878 W Krüger et al
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Subsequently, antibodies P717 and P718 were used for
immunocytochemical investigations. Differences in the pattern of
reactions were seen for both antibodies. The reaction of P717 with
breast cancer cells was weaker than expected. The staining pattern
of MCF7 cells is shown in Figure 4. Preferably parts of the apical
membrane were stained, however, in total ca. 15% of cells were
stained. Lymphatic cells were hardly detected by P717. Reaction
was strongest with the myeloid cell line K562 followed by breast
cancer line MCF7 and myeloid line HL60. For K562 the differ-
ences were significant (P = 0.02) in univariate analysis to all other
cells investigated. Data are presented graphically in Figure 6.
Pattern of reaction with P718 was different with generally lower
staining rates. Highest rates were again seen for myeloid line K562
followed by lymphoid line ST486 and breast cancer cell line
MCF7 (Figure 5). In this assay reaction with myeloid line HL60
and lymphoid line Namalwa was weak or absent, respectively
(Figure 6). Burkitt-lymphoma derived cell line Raji was neither
detected by P717 nor by P718.
DISCUSSION
The expression of the proteins BA46 and BA70, which are
expressed constitutively in the mammary epithelium was studied
in haemopoietic cell lines and tissue extracts were studied by
molecular and immunological methods. On the molecular level we
could clearly demonstrate that both messenger RNAs are ubiqui-
tously transcribed in myeloid and lymphatic cancer cell lines and
in bone marrow and blood stem cell samples obtained from
Figure 3 Western blot analysis with antibodies P717 (A) and P718 (B)
A) Western blot with P717, from left to the right: molecular mass symbols
(84 kD, 60 kD, 30.5 kD), K562, Raji, Namalwa, ST486, HL60, MDA-MB453,
MCF7 B) Western blot with P718, from left to the right: molecular mass
symbols (84 kD, 48.5 kD, 30.5 kD, 26.5 kD), Raji, Namalwa, K562, ST486,
HL60, MDA-MB453, MCF7
Figure 4 Staining of an MCF7 cell with polyclonal antibody P717
Figure 5 Staining of ST486 cells with polyclonal antibody P718
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Figure 6 Labelling of cells with polyclonal antibodies P717 (A) and P718
(A). Shown is the percentage of stained cells (MDA: MDA-MB453)HMF G-expression 879
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healthy volunteers and from patients with epithelial cancer. For
two reasons, the transcription of the BA46 and BA70 in myeloid
and lymphoid cell lines can not be regarded as phenomenon of
gene-dysregulation due to malignant transformation. First, two
myeloid lines of different stage of differentiation and three
lymphatic lines were included in the experiments. Differences
were not seen on the molecular level arguing for a constitutive
expression rather then a regulatory one. Second, results from
marrow and stem cell samples included from volunteers clearly
demonstrate that the transcription in haemopoietic tissue is ubiqui-
tous and not restricted to tumour cells. Larocca et al described 
an approximately 47% homology of the BA46 antigen to the blood
clotting factors V and VII (Larocca et al, 1991). Extended homo-
logies of the BA70 have not been described so far (Larocca et al,
1990). We could confirm the specificity of our rtPCR assays by
sequence analysis and sequence alignment in all cases performed.
Our samples included some specimens from patients with epithelial
cancer. Here, it could be argued that sequences could have been
amplified from disseminated cancer cells. However, results of
hybridization assays clearly exclude this possibility of interference.
To immunolocalize BA46 and BA70 a new approach using anti-
bodies against peptide-specific domains was performed. This
approach was chosen since monoclonal antibodies have been
made against both antigens, however, native BA46 and BA70 anti-
gens are highly glycosylated (Larocca et al, 1990, 1991).
Carbohydrates often alter the antigenicity of glycoproteins, thus a
non-reactivity of monoclonal antibodies with non-glycosylated
intracellular precursors could not be excluded. The ubiquitous
high-level transcription of BA46 and BA70 specific messenger
RNA suggests the synthesis of the proteins, at least as a non-glyco-
sylated precursor molecule. Therefore, our approach was to inves-
tigate the protein expression first by polyclonal peptide-specific
antibodies. Epitopes similar to those used were not found in
protein databases so far. By this way, we could detect a significant
reactivity of polyclonal antibodies P717 and P718 with total cell
proteins from breast cancer cells, myeloid and lymphoid cells.
The pattern of reactivity of both antibodies in immunocyto-
chemistry was different. BA46-derived antibody P717 showed a
strong reactivity with myeloid cell lines K562 and HL60. The
reactivity with lymphoid cells was weak or absent. In contrast,
P718 bounded likewise strongest to K562 cells followed by MCF7
and lymphoid line ST486. These differences in staining patterns
suggest at least differences in post-translational modifications
such as degree of glycosylation, and furthermore a function of
both proteins in haemopoietic cells. These results are hints that
BA46 (lactadherin) participates in the non-specific anti-infectious
function of myeloid cells (Newburg, 1999).
We conclude that mRNA of breast related antigens BA46 and
BA70 antigens is transcribed in haemopoietic cells independent
from their lineage, their state of differentiation, and their chromo-
somal gender. These findings argue for a vital role of these two
proteins in normal haemopoietic cells, however, to define their
physiological function further intensive research is necessary.
This study is corroborating earlier investigations concerning the
muc1, cytokeratins or carcinoembryonic antigen which clearly
show that the concept of lineage specific gene expression is at
least on the molecular no longer valid (Jung et al, 1998, 1999;
Dent et al, 1999).
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